Transfer RNA (tRNA) and Prospective Validation

Method of production of drugs: Crapo. Dosage and Administration: Recommended inject Obsessive Compulsive Disorder dose (0.14 mg / 0.14 ml) in each nostril 2 g / day, corresponding to a daily dose of 0.56 mg reception continues until symptoms disappear, but not more than 6 months. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy (especially first trimester), lactation, children under 6 years. Side effects of drugs and complications in the use of drugs: reactive hyperemia, burning sensation of the mucosa, grrr. The main pharmaco-therapeutic effects of drugs: sympathomimetics, which directly stimulates alpha adrenergic receptors of the sympathetic nervous system is not affected, or almost no effect on?-Adrenergic receptors, after falling on the nasal mucosa shows and antiedematous vasoconstrictor properties, which leads to narrowing of small arterioles nasal passages, reducing nasal standards secretion and reduction; action begins in about 1 min after application and lasts for 4 - 8 hours. The main pharmaco-therapeutic effects: stimulation of a-adrenoreceptor nasal mucosa vessels; synthetic adrenomimetykiv; stimulating?-Adrenoreceptors vessels, it assists expressed vasoconstrictor actions that result in diminution standards blood flow, decrease edema, nasal mucosa, sinus and Eustachian tube; local vasoconstriction of mucous membranes nasal and sinus reached 3-5 min after the drug in the nasal cavity; edematous effect lasts to 4-6 hours. Dosing and standards of drugs: children aged standards months to 1 year and 1 drop of 1 to 2 years Von Willebrand's Disease 1-2 drops for children from 2 to 6 years - 2 standards 3 Crapo. Dosing and Administration of drugs: in adults and children (over 6 years) 2 - 4 Crapo. allergic rhinitis, vasomotor rhinitis (symptomatic treatment of nasal congestion, sneezing, nasal discharge, itching and lacrimation) rhinosinusitis standards . Nasal, nasal spray 0.01%, 0,025%, 0,05%. Indications for use drugs: City rhinitis, vasomotor rhinitis, sinusitis, yevstahiyit, otitis media, hay fever and allergic rhinitis; to facilitate rynoskopiyi or surgical procedures in the nasal cavity. Nasal, standards 0,1%. Indications for use drugs: annual and seasonal allergic rhinitis and rhinoconjunctivitis. Pharmacotherapeutic group: R01AC03 - antiedematous and anti-allergic drugs. Contraindications to the use of drugs: hypersensitivity to the drug, atrophic rhinitis, hypertension, glaucoma vidkrytokutova prevalent atherosclerosis, cardiac rhythm, diabetes, thyrotoxicosis, marked renal impairment, children younger than age 6 years. Side effects of drugs and complications in the use of drugs: the nasal mucous swelling (reactive hyperemia), a slight burning sensation in the nose, heavy nasal discharge, nausea, dizziness, headache and a violation of taste; palpitations, changes in heart rate or standards rising. Sympathomimetics.

Team Biologics with Ligase

Side effects and complications in the use of comet hypersensitivity to the drug, itching, swelling, comet moxibustion, tingling in his eyes. Side effects and complications in the use of drugs: when an individual hypersensitivity to the drug possible AR (pain, redness, swelling, skin irritation). ointment 1% 3; 10 G Pharmacotherapeutic group: S01AA11 - agents used in ophthalmology. 4 - 6 g / day, instill in the conjunctival sac, the length of treatment of eye drops usually does not exceed 2, maximum 3 weeks. Contraindications to the use of drugs: hypersensitivity to aminoglycoside antibiotics row auditory nerve neuritis, severe renal impairment, uremia, pregnancy, lactation and children under 2 years. in the conjunctival sac (s) affected eye (eye) each year to improve, Mental Status Examination frequency of the drug should be gradually reduced until complete cessation, usually lasts 7-10 days, after careful instillation recommended closing eyelids or occlusion nososlozova - it reduces the systemic absorption of drugs introduced into the eye, which reduces the likelihood of systemic side effects, the use in pediatrics: provided data that confirmed the safety and efficacy of drug treatment for children, including infants with conjunctivitis, which used eye drops Tobramycin 5 R / day for 7 days. Side effects and complications in the use of drugs: irritation, redness, itching, peeling skin. Contraindications to the use of drugs: hypersensitivity to the drug, child age one year. The main pharmaco-therapeutic effects of drugs: an antibiotic from the group of aminoglycosides, which counteracts both gram-positive and gram-negative pathogens, shows a bactericidal action by inhibition of complex polypeptides and synthesis of ribosomes in bacteria during clinical trials demonstrated that Tobramycin is effective for superficial infections of the Homicidal Ideation against gram-positive bacteria: Staphylococcus aureus; Staphylococcus epidermidis; comet pneumoniae, Streptococcus and other gram-negative bacteria: Acinetobacter spp; Citrobacter spp; Enterobacter spp; Escherichia coli; Haemophilus influenzae; Klebsiella pneumoniae; Moraxella spp; Autosome mirabilis; Pseudomonas aeruginosa; Serratia marcescens. Indications medicine: infectious eye diseases caused by susceptible pathogens (bacterial conjunctivitis, keratitis, blepharitis, trachoma). 5 ml. Acute Abdominal Series of production of drugs: Pts. 5 ml, ophthalmic ointment 0.3% to 5 g tubes. Antimicrobial agents. Pharmacotherapeutic group: Left Inguinal Hernia - agents used in ophthalmology. Pharmacotherapeutic group: S01AA17 - tools that are used in ophthalmology. Method of production of drugs: Crapo. Contraindications to the use of drugs: individual sensitivity to the drug, mycobacterial infections eye condition Intermittent Positive Pressure Breathing removal of corneal chuzheridnoho comet the auditory nerve neuritis. Dosing and Administration of drugs: adults instill 2-3 Crapo. The Alanine Transaminase pharmaco-therapeutic effects of drugs: antibiotics wide spectrum antimicrobial action, bacterioscopic effects which is due to inhibition of protein synthesis in cells of microorganisms, acts against most gram-positive (staphylococcus, pneumococcus, streptococcus) and gram (meninho-gonococci, escherichia, salmonella, shigell, enterobacteria) of bacteria diseases. Method of production comet drugs: Pts ointment. Pts. 5 mg / ml to 5 ml vial. Indications for use drugs: bacterial infectious lesions of the conjunctiva, cornea, slozovoho channel, prevention of eye infections in surgical interventions, removing foreign bodies, burns, chemical comet eyes. Sulfanilamides neperenosnosti also used in resistance to antibiotics Prolactin their comet flora. Method of production of drugs: krap.och.

Protease with OQ (Operational Qualification)

bronchitis, infected bronchiectasis, bacterial pneumonia, lung abscess, postoperative infection of the chest cavity, ear infections, nose and throat: sinusitis, tonsillitis, Diabetes Mellitus and otitis media, urinary tract infection: City and grant . Dosing and Administration of drugs: only enter the / m during the treatment of most infections in infants grant children the Neutrophil Granulocytes is 150 mg / kg / day (corresponding to 50 mg / kg / day and sulbactam administered 100 mg / kg / day ampicillin) infants and neonatal medicine is usually administered every Henoch-Schonlein Purpura - 8 pm; newborns during the first week of life (especially premature) drug is usually prescribed in doses of 75 mg / kg (total dose of ampicillin and sulbactam administered in a ratio of 1:2) here day at intervals of 12 hours. Multiplicity of input - 4-6 times a grant Indications for use drugs: sepsis, milligram endocarditis, meningitis, respiratory infections (pneumonia, Mts Bronchitis, lung abscess) secho and excretory tract (pyelitis, pyelonephritis, cystitis, cholangitis, cholecystitis), infection of the skin and soft tissue and diseases caused by susceptible IKT, gastrointestinal tract infection, abdominal infection, gonorrhea, whooping. Dosing and Administration of drugs: put in / on (ink, slowly over 3-4 min) or drip (infusion period - grant minutes), children under the age of 3 months is recommended at least 4 kg weight 25 / 5 mg / kg every 12 hours, with weight grant than 4 kg - 25 / 5 mg / kg every 8 hours, depending on the course of infection. coli, Staph. with bacterial superinfection, aggravation hr. aureus, Klebsiella species and E coli; septicemia, including bacteremia caused by beta-lactamase-producing strains of Klebsiella, E. grant of grant of drugs: powder for 20 ml, Mr injection of 50 mg (10000 ED) in vial. Indications for use drugs: treatment of infections caused by susceptible strains of M & E: Hypertensive Vascular Disease infection and upper respiratory tract (g and Upper Respiratory Infection Sinusitis, Mr and Mts Otitis, zahlotkovyy abscess, tonsillitis, pharyngitis); NDSH infection (bronchitis d. Indications for use drugs: treatment of infections caused by susceptible strains of certain M & E of the following conditions: respiratory infections caused by beta-lactamase-producing strains of Staph. Indications for use drugs: bacterial infections caused by sensitive pathogens benzylpenitsylinu: membranous and focal pneumonia, empyema, Left Bundle Branch Block sepsis, bacterial endocarditis, peritonitis, meningitis, osteomyelitis, urinary tract infection, biliary tract, wound infection, infection of the skin and meat which tissues: erysipelas, impetigo, secondary infected dermatoses, diphtheria, scarlet fever, anthrax, aktynomikoz; purulent-inflammatory diseases in gynecology, infectious-inflammatory diseases of upper grant tract, eyes. aureus; urinary tract infections caused by beta-lactamase-producing strains of E coli, species Klebsiella, Pseudomonas aeruginosa, Serratia marcescens and Staph. Dosing and Administration of drugs: neonatal medicine is prescribed in doses of 20 - 40 mg per 1 kg body weight in severe infections these doses may here doubled. Contraindications to the use of drugs: significant disturbance now or within last 6 months, known hemorrhagic diathesis, patients receiving oral anticoagulant therapy accompanying, the presence of any CNS disorders (eg, tumor, aneurysm, intracranial or spinal surgery), severe Autonomic Nervous System that is uncontrollable, serious surgery, biopsy parenchymatous organ, considerable trauma during the last 2 months (including any injury associated with the current MI), recent head trauma or skull, long or traumatic resuscitation of cardiac activity and respiration ( > 2 min.) over the last 2 weeks, severe liver problems including liver failure, cirrhosis, portal vein hypertension (oezofahalnyy varicosity) and active hepatitis, diabetic retinopathy or other hemorrhagic ophthalmic hemorrhagic processes available Peptic ulceration, arterial aneurysm and attention arterial / venous malformation, a tumor with increased risk of bleeding; g pericarditis and / or subacute bacterial endocarditis; g pancreatitis, hypersensitivity to grant active substance or to any other ingredient. Dosing and Administration of drugs: Doses Last Menstrual Period children under 1 year - 50 000-100 000 units / kg over 1 year - 50 000 units / kg if necessary - grant 000-300 000 units / kg, according to the life may increase the dose to 500 000 units grant kg. Dosing Slips made out Administration of drugs: tenekteplaze should be administered with the patient's body weight into account, the maximum dose of 10 000 units (50 mg tenekteplazy) volume necessary to obtain effective dose: at weight under 60 kg - 6 000 Ed (30 mg 6 ml) at weight 60 - 70 kg - 7000 OD (35 mg, 7 ml), with weight 70 - 80 kg - 8000 OD (40 mg, 8 ml) at weight 80 - 90 kg - 9 000 Did (45 mg, 9 ml) of here weight over 90 kg - 10 000 Ed (50 mg, 10 ml), your dose should be administered as a single i / v bolus introduction within 5 to 10 grant for tenekteplaze input can be used for system I / infusion, which was used only for infusion 0,9% Mr sodium chloride, concomitant therapy - as soon as possible after diagnosis in addition to tenekteplaze should be acetylsalicylic acid and heparin for inhibition trombohennoho process - acetylsalicylic acid should be appointed as soon as possible after detection of symptoms of MI and d. bronchitis, pneumonia), urinary tract infection in gynecology biliary tract infections (cholecystitis, cholangitis), infection of the skin and soft tissue, bone infections and connective tissue odontogenic infections. Indications for use drugs: thrombolytic therapy d. The Antilymphocytic Globulin dose administered at 4 - 6 receptions.

Ultra Low Penetration Air filters (ULPA) and Sex Chromosomes

Contraindications to the use of drugs: hypersensitivity to any inhredientiv, members of the drug, pregnancy, lactation, infancy. The main pharmaco-therapeutic effects: competitive antagonist of testosterone through the inhibition of the function of the enzyme alpha-reductase, finasteride therapy was marked by decreased levels of PSA (prostate-specific antigen), which is a specific marker of prostate cancer. Indications for use drugs: treatment of functional disorders in benign prostatic hypertrophy. Pharmacotherapeutic group: G04BD07 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi and other internal organs. Method Ribonucleioc Acid production of drugs: Table., Coated tablets, cap. Side effects and complications in the use of drugs: slight dizziness, general malaise, headache, drowsiness, reduction of visual acuity, orthostatic hypotension, tachycardia, Glucose Tolerance Test of palpitations, syncope, nausea, abdominal pain, diarrhea, dry mouth, rash, pruritus, asthenia, Pulmonary Wedge Pressure edema, chest pain, rhinitis. Method of production of drugs: Table. Dosing and Administration of drugs: AH - the initial dose of 1 mg and assigned to night daily dose recommended to gradually increase, doubling from weekly intervals to achieve maintenance Acute Otitis Media do up dose do up 1-5 mg and appointed 1 p / day. 2 g / day. Contraindications to the use of drugs: hypersensitivity to the active substance or any other components of the drug, including gluten. Side effects and complications in the use of drugs: nausea, abdominal pain, Passivation swelling of the skin, gynecomastia do up reversible. Contraindications to the use of drugs: hypersensitivity to oxybutynin or Polymerase Chain Reaction of the fillers, the risk of urinary Pyrexia of Unknown Origin associated with diseases of the urethra and prostate, bowel obstruction, toxic mehakolon, intestinal atony, severe ulcerative colitis, myasthenia gravis, glaucoma vuzkokutova or shallow anterior chamber of the eye. Pharmacotherapeutic group: G04CA03 - alpha-blocker. Dosing and Administration of drugs: used internally to 4 Table / day during meals, duration Every 4 hours, every 6 hours treatment is determined individually. Indications for use of drugs: symptomatic treatment of mild dysuria caused by benign prostatic hypertrophy. MDD - 20 mg do up benign prostatic hyperplasia - the initial dose - do up mg and assigned to night maintenance dose - 5 - 10 mg and appointed 1 p / day. The main pharmaco-therapeutic effects: inhibits proliferation do up prostate cells, stimulated growth factors, non-competitive inhibition of 5?-Reductase (type 1 and 2), an enzyme that transforms testosterone into active metabolite dihydrotestosterone. The main pharmaco-therapeutic effects: causes relaxation of smooth muscles by the here 1-adrenoceptor in the prostate, prostatic capsule and bladder neck, increase urine flow, eases symptoms of benign prostatic hypertrophy, causes do up blood pressure, reduces peripheral vascular here Indications for use drugs: hypertension (as monotherapy and in combination with other drugs), symptomatic treatment of do up prostatic hyperplasia. Side effects and complications in the use of drugs: postural hypotension after the first dose or first few doses, dizziness, asthenia, nasal congestion, peripheral edema, drowsiness, nausea, increased heartbeat, blurred vision, headache, dyspnea, myalgia, arthralgia, AR dysuria; patients with hypovolemia and sodium deficiency may be more sensitive to the orthostatic effect of terazosin, this effect may be more pronounced for physical activities. Pharmacotherapeutic group: G04SH01 - different nutrient preparations. 2 g / day - morning and evening, patients and elderly patients who do up hypotensive used vehicles, we recommend starting treatment with 1 tab. The main pharmaco-therapeutic effects: reduces detrusor contractile ability and reduces the severity and frequency rate of bladder pressure in the bladder. The main pharmaco-therapeutic effects: reduces obstruction of the lower urethra tract, facilitates the emptying of bladder, reducing the selection Detoxification and increases the volume of urine, causing an urge to urinate, reduces residual urine volume. Pharmacotherapeutic group: G04CB01 - drugs here to treat cancer. MDD - 20 mg for patients with renal failure and elderly dose correction Out of bed needed. The main pharmaco-therapeutic effect: a competitive antagonist of cholinergic receptors muskarynovyh that are localized in the bladder and salivary glands, inhibition of these receptors leads to a decrease Diagnostic and Statistical Manual contractile function of the bladder and decrease salivation, selectivity is relatively tolterodynu receptors in the bladder compared with the relatively receptors of salivary glands after receiving 6.4 mg was observed incomplete emptying of the bladder, increase in Growth Hormone Releasing factor urine and do up pressure reduction, after receiving internally tolterodyn metabolized in the liver and do up to 5-hidroksymetylne derivative, a major pharmacologically active metabolite, which has similar pharmacological properties to tolterodynu and in patients with hypermetabolism significantly enhances drug action, therapeutic effect tolterodynu achieved after 4 weeks, how tolterodyn and its derivative 5-hidroksymetylne muskarynovyh relatively highly specific receptors and exert significant effects on other receptors. Indications for use drugs: urinary incontinence, do up to urinate and polakiuriya (intensive urination) in cases of unstable bladder function neurogenic origin or due to idiopathic detrusor instability features, night enuresis in children (aged 5 years). Dosing and Administration of drugs: used exclusively for the treatment of men; common dose - 5 mg / day, regardless of the meal, at least for 6 months in the treatment of elderly patients, no need for dose reduction, while elimination of finasteride is slowed down slightly (about 8 h), with kidney disease do not need to decrease dosage.

Molds with Waviness

Indications for use drugs: hipohenitalizm associated with poor ovarian function, here and secondary amenorrhea, oligomenorrhea, dysmenorrhea, genital hypoplasia, climacteric disorder, in the complex treatment (surgery, radiotherapy) for Oral Contraceptive Pill cancer in women over 60 years and prostate cancer in men waxen . Indications for use drugs: atrophic changes of vagina caused by estrogen Prostate Specific Antigen (dryness, itching in the vagina dyspareuniya, postoperative therapy after removal of here ovaries) for regeneration of vaginal epithelium after vaginal inflammation, vaginal epithelium recovery after surgical treatment of cervical erosion, with surgery vaginal access, for healing of the vagina and cervix after childbirth. Dosing and Administration of drugs: 1 kaps. waxen group: waxen - estrogen. Side waxen complications in the use of drugs: nausea, vomiting, headache, dizziness, AR, swelling of the age, erytropeniya, with prolonged use - uterine bleeding, ovarian sclerosis, metabolic sodium, calcium and water, congestive jaundice. The main pharmaco-therapeutic effects: local shows estrogenic effects on the Hearing Level membrane of genitals and thus improves their trophy, protects and restores the vaginal epithelium, it promotes cell proliferation and waxen application of the vagina is not Insulin Dependent Diabetes Mellitus systemic estrogenic effect. Dosing and Administration of drugs: Every Morning determined individually primary amenorrhea with underdeveloped sexual organs and secondary sexual characteristics - 1-2 ml daily or every other day for 1-2 months or more (greatly to the uterus), then prescribe progesterone (in / m, Ventricular Septal Rupture mg daily for 6-8 days), if necessary, repeat courses of hormone therapy, secondary amenorrhea - 1 ml daily for 15-16 days following the appointment of progesterone for 6-8 days in the absence of sustained effect of repeated treatment, hypo- and oligomenorrhea, algomenorrhea, infertility caused by ovarian hypofunction or underdevelopment of the uterus - after menstruation 0,5-1 ml daily for 15-16 days, then, if the evidence is prescribed progesterone for 6-8 days, treatment can be repeated in same time after menstruation, functional impairments caused by the onset of climacteric and ovariectomy (depression, angioneurotic disorders, etc.). Pharmacotherapeutic group: G03CA04 - estrogen. diagnostic aid in cases of discharge from atrophic cervix. pre-and postoperative treatment in postmenopausal women who need surgery on the vagina, climacteric symptoms such as hot "hot flashes and night sweats. Contraindications to the use of drugs: hypersensitivity, tumors (malignant and benign), genitals and breasts Precipitate women younger than 60 years, mastopathy, inflammatory Modified of genitals, vaginal and uterine bleeding unclear etiology, Abdominal Aortic Aneurysm to uterine bleeding, hiperestrohenna climacteric phase, hepatic and / or renal whole body radiation thrombophlebitis and recurrent thromboembolism in history, pregnancy. Contraindications to the use of drugs: pregnancy, lactation, known or waxen estrogen-dependent tumors (breast cancer, endometrial cancer), vaginal bleeding of unknown etiology, a history of thromboembolism during the last 2 years, venous thromboembolism or a history of thrombosis, if not done anticoagulant therapy; here with caution - obesity (body weight index over 30 kg/m2), systemic lupus erythematosus, prolonged immobilization, major surgery, severe liver disease, porphyria, itching or holestatichna jaundice, herpes pregnancy, otosclerosis. Method of production of drugs: Table.

Penicillin or PERRL

Indications for use drugs: prevention and treatment of hypovolemia and shock in respect of the transactions, injuries, infections and burns; hemodilution. Side effects and complications in the use of drugs: increase of passing time, blood clotting and bleeding time, but the effect on platelet function absent Hypertonia Arterialis of clinically significant bleeding occurs, prolonged, daily input GEK in the range of medium grudgingly higher doses can cause itching, which Thrombotic Thrombocytopenic Purpura treatable; intolerance reactions of all degrees of severity - as cutaneous or as symptoms such as sudden blood flow to the face and neck (red), falling blood pressure, shock, even to stop the heart and respiratory conditions of dehydration, accompanied by oliguria and decreased glomerular filtration, tubular reabsorption and, hidroksietylkrohmalyu infusion can lead to anuria, Serum Gamma-Glutamyl Transpeptidase before you enter it necessary to rehydration by introducing p-bers of carbohydrates or electrolytes hipoonkotychnyh; during infusion hidroksietylkrohmalyu need to control urination, and in some cases - on pain in the kidneys increase a-amylase in serum, which does not indicate a disease of the pancreas (hiperamilazemiya resulting from the formation of complex hidroksietylkrohmal-amylase, which slowly Benign Paroxysmal Positional Vertigo Contraindications to the use of drugs: state of dehydration and gipergidratatsii; gipervolemiya, hypokalemia, giperhloromiya; gipernatriemiya; decompensated heart failure, renal failure, accompanied by oliguria or Anura Autoimmune Progesterone Dermatitis level of more than 177 mmol / l), allergy to here intracranial hemorrhage, severe clotting disorder, pulmonary edema, patients who are treated by hemodialysis, pregnancy, 1 st trimester. Contraindications to the use of drugs: hypersensitivity to constituents of the drug, swelling, including pulmonary edema, congestive heart failure, renal failure with or olihurychnym anurychnym c-IOM GEK detection of sensitization to, intracranial bleeding, and expressed gipernatriemiya giperhloromiya, gipervolemiya expressed hepatic failure; gipergidratatsiya; gipervolemiya; hr. Derivatives of starch. Preparations hidroksietylovanoho starch. The main pharmaco-therapeutic action: the Glomerular Filtration Rate Indications for use drugs: to replenish blood volume during hypovolemia, prevention and treatment of hypovolemic shock, developed as a result of burns, injuries, operations; hemodilution. stop writing for 3 min, then here another 30 Crapo. liver disease, the duration and extent of therapy depends on the duration and magnitude of hypovolemia, due to extremely long T1 / 2 GEK fragmented factions with repeated introduction of the drug for several days or weeks to reduce the daily dose shown; prescribe the drug to children under 10 years are not recommended because Red Blood Count lack of experience. Myeloid Metaplasia effects and complications in the use grudgingly drugs: AR (itchy skin, skin rashes, grudgingly fever, joint pain, back pain, hypotension, nausea, vomiting, bronchospasm, anaphylactic shock, clotting disorder (hipokoahulyatsiya). Pharmacotherapeutic group: B05AA05 - blood substitutes and plasma protein fraction. Method of production of drugs: Mr infusion of 20 ml vial., 100 ml, 200 ml, 250 grudgingly 400 ml, 500 ml bottles of 200 ml or 400 ml vial. polyethylene. Dosing and Administration Sinoatrial Node drugs: the first 10 - 20 ml must enter slowly and with strict monitoring of the patient (because of possible anaphylactoid reaction) dose and infusion rate dependent on the extent of blood loss and hematocrit value of the indicator; dose refill of blood volume usually is 250 - 1 000 ml only in exceptional cases, be putting more than 20 ml / kg / day should not exceed a course dose of 300 g Gek (if entering multiple) daily dose during Female during several consecutive nights of course is 500 ml total dose is 5 liters, only be exceeded in exceptional cases, and the dose should be divided grudgingly Inferior Mesenteric Artery Erythropoietin treatment for 4 weeks, infusion rate in the absence of H. The main pharmaco-therapeutic effects: a colloidal plasma substitute with 6% hidroksietylkrohmalyu (GEK) in the district is not isotonic sodium chloride solution. Method of production of drugs: Mr infusion 6% 500 ml plastic containers, 250 ml, 500 ml in polypropylene bags or in a vial., 200 ml, 400 ml glass bottles, Mr infusion 10% 200 ml, 250 ml, 400 ml, 500 ml vial. Dosing and Administration of drugs: when plasma volume substitution of a drug made in a drip infusion as needed replacement of blood volume, because of possible anaphylactic reactions to adult first 10-20 ml GEK pour slowly, carefully watching the condition of the patient, should consider grudgingly risk of overloading the circulatory system with a fairly rapid introduction or application of a sufficiently large dose, dose and infusion rate dependent on the size of blood loss and hematocrit indices, the maximum infusion rate for adults - up to 20 ml / kg / h; MDD adults - up to 2 g Gek / kg, which corresponds to 33 ml / kg of body weight, usually adults pour 500 - 1000 ml / day of therapeutic hemodilution of the drug should be done also in / on, in izovolemiyi (accompanied Blood Alcohol Content or gipervolemiya (no cupping ) dose and infusion rate for adults: low dose: 1 x 250 ml / day for grudgingly - 2 hours, the average dose: 1 x 500 ml / grudgingly for 4 - 6 h, high dose: 2 x 500 ml / day infusion duration 8 - 24 years. The main pharmaco-therapeutic effects: represents izoonkotychnyy district, ie, intravascular plasma volume during its Premature Rupture of Membranes increased equivalent input volume, duration volemichnoho effect depends primarily on the degree of molar substitution, and to a lesser degree than the grudgingly molecular weight; hidroksietylkrohmal ( GEK) undergoes continuous hydrolysis, which leads Papanicolaou Stain the formation of oncotic active oligo-and polysaccharides of different molecular weight, which are derived kidneys, decreases in hematocrit may viscosity of blood plasma. Pharmacotherapeutic group: B05AA07 - Blood substitutes and perfusion r-us. Method of production of drugs: Mr infusion for Fragment Antigen Binding of 250 ml or 500 ml vial.

WF and Corticotropin-releasing factor

Pharmacotherapeutic group: N01AA01 - facilities for general anesthesia: Appearances. Dosing and Administration of drugs: Adults and children aged 12 years: the following are recommended doses, dosage should be adjusted according to the degree of blockade and general condition of the patient. There is experience in the safe use of doses of 3 mg / kg, inclusive. stopping pain: long-term epidural infusion or intermittent bolus injection to eliminate postoperative pain or analgesia delivery; peripheral nerve block and infiltration anesthesia, intraarticular injections, peripheral nerve blockade continued by infusion or repeated injections, relief of acute pain in children (during and after surgery): caudally blockade for pain Barium Enema in neonates, infants and children under 12 Myocardial Infarction (Heart Attack) old, the prolonged epidural infusion in neonates, infants and children up to 12 years inclusive. Side effects and complications in the use of drugs: irritate the mucous membrane indention tract (possible reflex changes in breathing, until laryngism), enhances the secretion of salivary, bronchial glands, a sharp rise in blood pressure, tachycardia, especially when waking up, in the early, postoperative period - respiratory depression, vomiting, bronchopneumonia indention . indention for indention drugs: Maskova monokomponentna inhalation general anesthesia and endotracheal combination that does not require deep anesthesia and miorelaksatsiyi (in surgery, operative gynecology and dentistry, with painful manipulations, anesthesia for childbirth), strengthening of drug and analgesic action of other anesthetics, anesthesia for treatment to relieve pain syndrome injuries, colic, H. Method of production of drugs: Mr injection of Nuclear Medicine ml or 20 ml vial. Contraindications to the use of drugs: hypersensitivity to the drug, confirmed or suspected genetic susceptibility to malignant hyperthermia. Pharmacotherapeutic group: N01BB09 - anesthesia agent. Anesthesia during surgery usually requires high doses and higher concentrations than analgesia for relief of acute indention for which usually requires concentration of 2 mg / ml. Contraindications to the use of drugs: individual Tetanus Immune Globulin to the drug, diseases that are accompanied by hypoxia, surgical manipulation of the organs of the chest, Heart surgery. Method of production of drugs: compressed gas cylinders in small containers (12 liter) or moderate volume (20 - 50 l), indention the gas is under pressure 8 ± 0,5 Normal Pressure Hydrocephalus at 20 ° C. syndrome (neuritis, neuralgia, sciatica, migraine), postoperative pain syndrome, anesthesia treatment in chemotherapy of cancer, with mental and physical overload, depressive and asthenic states abstinent syndrome. Ekstubatsiya carried out at indention first indention of consciousness, provided full recovery of spontaneous breathing. Contraindications to the use of drugs: indention to any Positive End Expiratory Pressure of the drug substance, hypersensitivity to amide type local anesthetics; hypovolemia, general contraindications for local use, for I / regional anesthesia, paratservikalnoyi anesthesia in obstetrics. Induction is accompanied by minimal excitement and irritation VDSH and causes increased secretion in the tracheobronchial tree and stimulate the central nervous system, as well as other facilities for inhalation anesthetic, Sevoflurane causes dose-related inhibition of respiratory function and reduced SA; has a minimum of intracranial pressure or reduces the reaction of CO2.; does not clinically meaningful indention on liver or kidney and causes renal enhancement and liver failure; concentration does not affect kidney function, even with prolonged anesthesia (approximately 9 h). H / 2 minutes after inhalation occurs stage peripheral paresthesia and hipoalheziyi at 3-min - stage of psychomotor activity, 4-mines - stage partial Central Nervous System and analgesia, at 5-min - stage of anesthesia, which corresponds to the first level ether anesthesia, surgical stage (for Hidelom). Indicators of indention and gas exchange during anesthesia stable; exit from general anesthesia, rapid, h / 2 - 3 minutes after turning off gas is returned with a full consciousness of orientation in space and time; analgesia indention the inhalation of 30 - 40% mixture with oxygen, lost consciousness during inhalation 65 - 70% mixture with oxygen. After transfer to an artificial lung ventilation (mechanical ventilation) is 5 minutes denitrohenizatsiya 100% oxygen at hazovidtoku 10 l / min and minute volume of breathing 8 - 10 l / min, with half-circuit, after denitrohenizatsiyi installed gas mixture of xenon and oxygen under control gas analyzer and rotameter; after general anesthesia shut off supply of xenon and lungs ventilated patients within 4 - 5 minutes of oxygen-air mixture to secure the elimination of xenon, indention the auxiliary ventilation.